Matches in Wikidata for { <http://www.wikidata.org/entity/Q83826953> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q83826953 description "article scientifique publié en 2012" @default.
- Q83826953 description "artículu científicu espublizáu en marzu de 2012" @default.
- Q83826953 description "im März 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83826953 description "scientific article published on 23 March 2012" @default.
- Q83826953 description "wetenschappelijk artikel" @default.
- Q83826953 description "наукова стаття, опублікована в березні 2012" @default.
- Q83826953 name "Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current T" @default.
- Q83826953 name "Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current T" @default.
- Q83826953 type Item @default.
- Q83826953 label "Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current T" @default.
- Q83826953 label "Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current T" @default.
- Q83826953 prefLabel "Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current T" @default.
- Q83826953 prefLabel "Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current T" @default.
- Q83826953 P1433 Q83826953-02B59F2E-F11F-4517-97CA-0341D3C6C310 @default.
- Q83826953 P1476 Q83826953-4F6787FE-5A59-4DE2-A6D1-F3B320ABF5A2 @default.
- Q83826953 P2093 Q83826953-27F5B723-44FC-4066-8EC2-F7A9BFDFCA9E @default.
- Q83826953 P2093 Q83826953-58264FF0-7F83-4067-951E-67540F85AFD1 @default.
- Q83826953 P2093 Q83826953-F9C7766A-CC32-47A6-BCF7-C486BB5DE93D @default.
- Q83826953 P304 Q83826953-87FCD83B-2108-41BD-A887-C0AA4265503D @default.
- Q83826953 P31 Q83826953-6549622B-2773-43FC-8173-37F403A532CB @default.
- Q83826953 P356 Q83826953-D5A41E3B-3C1E-4FE1-A1B3-8295A25651C5 @default.
- Q83826953 P433 Q83826953-A6EC585E-2FA2-47D3-9FFB-2CA0C1ACFD24 @default.
- Q83826953 P478 Q83826953-B11EEFF2-63E9-495E-B3C6-249B00CA9B39 @default.
- Q83826953 P577 Q83826953-6D114CA7-B88F-42F0-9102-6CA3001FF9D5 @default.
- Q83826953 P698 Q83826953-56D1C207-F1A9-4EAA-A357-F046CA904F12 @default.
- Q83826953 P356 J.EURURO.2012.03.033 @default.
- Q83826953 P698 22482779 @default.
- Q83826953 P1433 Q15763991 @default.
- Q83826953 P1476 "Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol. In press. DOI:10.1016/j.eururo.2012.01.019" @default.
- Q83826953 P2093 "Momokazu Gotoh" @default.
- Q83826953 P2093 "Naoto Sassa" @default.
- Q83826953 P2093 "Toyonori Tsuzuki" @default.
- Q83826953 P304 "e61" @default.
- Q83826953 P31 Q13442814 @default.
- Q83826953 P356 "10.1016/J.EURURO.2012.03.033" @default.
- Q83826953 P433 "6" @default.
- Q83826953 P478 "61" @default.
- Q83826953 P577 "2012-03-23T00:00:00Z" @default.
- Q83826953 P698 "22482779" @default.